{"title":"Plum A+ infusion pumps - potential failure","public_updated_at":"2014-12-17T14:56:15Z","details":{"metadata":{"alert_type":"devices","issued_date":"2011-06-08","medical_specialism":["anaesthetics","critical-care","paediatrics","theatre-practitioners"],"bulk_published":true,"document_type":"medical_safety_alert"},"change_history":[],"body":[{"content_type":"text/html","content":"<h2 id=\"device\">Device</h2>\n\n<p><img src=\"https://assets.digital.cabinet-office.gov.uk/media/5485ac1e40f0b60244000295/con120288.jpg\" alt=\"Plum A+ infusion pump\" /></p>\n\n<p>All Plum A+ infusion pumps:  </p>\n\n<table>\n  <tbody>\n    <tr>\n      <td> Pump</td>\n      <td>&nbsp;</td>\n      <td> List number</td>\n    </tr>\n    <tr>\n      <td> Plum A+ Infusion Pump</td>\n      <td>&nbsp;</td>\n      <td> 11971</td>\n    </tr>\n    <tr>\n      <td> Plum A+ 3 Infusion Pump System v 10.3</td>\n      <td>&nbsp;</td>\n      <td> 12348</td>\n    </tr>\n    <tr>\n      <td> Plum A+ Infusion Pump v 11.3</td>\n      <td>&nbsp;</td>\n      <td> 12391</td>\n    </tr>\n    <tr>\n      <td> Plum A+ 3 Infusion Pump v 11.3</td>\n      <td>&nbsp;</td>\n      <td> 12618</td>\n    </tr>\n    <tr>\n      <td> Plum A+ 3 with Hospira MedNet Software</td>\n      <td>&nbsp;</td>\n      <td> 20678</td>\n    </tr>\n    <tr>\n      <td> Plum A+ Driver</td>\n      <td>&nbsp;</td>\n      <td> 20792</td>\n    </tr>\n  </tbody>\n</table>\n\n<p>Manufactured by Hospira Inc.</p>\n\n<h2 id=\"problem\">Problem</h2>\n\n<p>Risk of delay or interruption to treatment.</p>\n\n<p>The audible alarm on all listed Plum A+ infusion pumps may fail.</p>\n\n<p>The visual alarm is not affected. However, if the user does not notice the visual alarm they may be unaware of an interruption to the infusion eg air-in-line or occlusion.</p>\n\n<p>Improper mounting of components, poor soldering, and breakage of internal wiring connections may lead to failure of the audible alarm.</p>\n\n<p>The <a rel=\"external\" href=\"https://assets.digital.cabinet-office.gov.uk/media/5485ac1c40f0b6024100027b/con111685.pdf\">manufacturer’s FSN</a> (905Kb) advises users to test the audible alarm before each use of the pump as an interim measure. However, these tests will not predict if the audible alarm will fail and will only indicate if it has already failed. It is possible for the audible alarm to fail in use, even after the test has been performed.</p>\n\n<p>Hospira is modifying the design of the audible alarm to resolve this problem. Once this has been completed, Hospira will contact users to arrange for replacement.</p>\n\n<h2 id=\"action\">Action</h2>\n\n<ul>\n  <li>Identify affected pumps.  </li>\n  <li>Consider using an alternative device if an undetected interruption to an infusion could compromise patient safety.  </li>\n  <li>If an alternative is not available, perform the pre-use checks detailed in the manufacturer’s <a rel=\"external\" href=\"https://assets.digital.cabinet-office.gov.uk/media/5485ac1c40f0b6024100027b/con111685.pdf\">manufacturer’s FSN</a> (905Kb) (dated 2 March 2011). Be aware that the audible alarm may still fail in some pumps even after the checks have been completed.  </li>\n</ul>\n\n<h2 id=\"distribution\">Distribution</h2>\n\n<p>This MDA has been sent to:  </p>\n\n<ul>\n  <li>NHS trusts in England (Chief Executives)  </li>\n  <li>Care Quality Commission (CQC) (Headquarters) for information  </li>\n  <li>HSC trusts in Northern Ireland (Chief Executives)  </li>\n  <li>NHS boards in Scotland (Equipment Co-ordinators)  </li>\n  <li>Local authorities in Scotland (Equipment Co-ordinators)  </li>\n  <li>NHS boards and trusts in Wales (Chief Executives)  </li>\n  <li>Primary care trusts in England (Chief Executives)  </li>\n  <li>Social services in England (Directors)  </li>\n</ul>\n\n<h4 id=\"onward-distribution\">Onward distribution</h4>\n\n<p>Please bring this notice to the attention of relevant employees in your establishment. Below is a suggested list of recipients.</p>\n\n<p>Trusts<br />\nCAS and SABS (NI) liaison officers for onward distribution to all relevant staff including:  </p>\n\n<ul>\n  <li>A&amp;E departments  </li>\n  <li>Adult intensive care units  </li>\n  <li>All wards  </li>\n  <li>Biomedical engineering staff  </li>\n  <li>Clinical governance leads  </li>\n  <li>EBME departments  </li>\n  <li>Equipment stores  </li>\n  <li>Health and safety managers  </li>\n  <li>In-house maintenance staff  </li>\n  <li>IV nurse specialists  </li>\n  <li>Medical directors  </li>\n  <li>Nursing executive directors  </li>\n  <li>Operating departments  </li>\n  <li>Paediatric intensive care units  </li>\n  <li>Pain control teams  </li>\n  <li>Risk managers  </li>\n  <li>Supplies managers  </li>\n  <li>Theatres  </li>\n</ul>\n\n<p>Primary care trusts<br />\nCAS liaison officers for onward distribution to all relevant staff including:  </p>\n\n<ul>\n  <li>Community hospitals  </li>\n  <li>Hospital at home  </li>\n  <li>Equipment libraries and stores  </li>\n  <li>Palliative care teams  </li>\n</ul>\n\n<p>Social services<br />\nLiaison officers for onward distribution to all relevant staff including:  </p>\n\n<ul>\n  <li>Care management team managers  </li>\n  <li>Equipment supplies managers  </li>\n  <li>In-house residential care homes  </li>\n  <li>Loan store managers  </li>\n</ul>\n\n<h4 id=\"independent-distribution\">Independent distribution</h4>\n\n<p>Establishments registered with the Care Quality Commission (CQC) (England only)<br />\nThis alert should be read by:  </p>\n\n<ul>\n  <li>Care homes providing nursing care (adults)  </li>\n  <li>Clinics  </li>\n  <li>Hospices  </li>\n  <li>Hospitals in the independent sector  </li>\n</ul>\n\n<p>Please note: CQC and OFSTED do not distribute these alerts. Independent healthcare providers and social care providers can sign up to receive MDAs directly from the Department of Health’s Central Alerting System (CAS) by sending an email to: <a href=\"&#109;&#097;&#105;&#108;&#116;&#111;:&#115;&#097;&#102;&#101;&#116;&#121;&#097;&#108;&#101;&#114;&#116;&#115;&#064;&#100;&#104;&#046;&#103;&#115;&#105;&#046;&#103;&#111;&#118;&#046;&#117;&#107;\">&#115;&#097;&#102;&#101;&#116;&#121;&#097;&#108;&#101;&#114;&#116;&#115;&#064;&#100;&#104;&#046;&#103;&#115;&#105;&#046;&#103;&#111;&#118;&#046;&#117;&#107;</a> and requesting this facility.  </p>\n\n<h2 id=\"manufacturer-contact\">Manufacturer contact</h2>\n\n<div class=\"address\"><div class=\"adr org fn\"><p>\n\nRobert Cookes  \n<br />Customer Services Manager  \n<br />Hospira UK  \n<br />Queensway  \n<br />Royal Leamington Spa  \n<br />CV31 3RW\n<br />\n<br />Tel: 0800 028 7304  \n<br />Fax: 0800 028 7305  \n<br />\n</p></div></div>\n\n<p>Email: <a href=\"&#109;&#097;&#105;&#108;&#116;&#111;:&#099;&#117;&#115;&#116;&#115;&#101;&#114;&#118;&#064;&#104;&#111;&#115;&#112;&#105;&#114;&#097;&#046;&#099;&#111;&#109;\">&#099;&#117;&#115;&#116;&#115;&#101;&#114;&#118;&#064;&#104;&#111;&#115;&#112;&#105;&#114;&#097;&#046;&#099;&#111;&#109;</a></p>\n\n<h2 id=\"feedback\">Feedback</h2>\n\n<p>If you have any comments or feedback on this Medical Device Alert, please email us at: <a href=\"&#109;&#097;&#105;&#108;&#116;&#111;:&#100;&#116;&#115;&#064;&#109;&#104;&#114;&#097;&#046;&#103;&#115;&#105;&#046;&#103;&#111;&#118;&#046;&#117;&#107;\">&#100;&#116;&#115;&#064;&#109;&#104;&#114;&#097;&#046;&#103;&#115;&#105;&#046;&#103;&#111;&#118;&#046;&#117;&#107;</a> </p>\n\n<h2 id=\"england\">England</h2>\n\n<p>If you are in England, please send enquiries about this notice to the MHRA, quoting reference number MDA/2011/066 or 2011/003/014/291/003.</p>\n\n<h4 id=\"technical-aspects\">Technical aspects</h4>\n\n<div class=\"address\"><div class=\"adr org fn\"><p>\n\nSharon Knight or Roopa Prabhakar  \n<br />Medicines &amp; Healthcare products Regulatory Agency  \n<br />Floor 4  \n<br />151 Buckingham Palace Road  \n<br />London  \n<br />SW1W 9SZ\n<br />\n<br />Tel: 020 3080 7202 or 7293  \n<br />Fax: 020 8754 3965  \n<br />\n</p></div></div>\n\n<p>Email: <a href=\"&#109;&#097;&#105;&#108;&#116;&#111;:&#115;&#104;&#097;&#114;&#111;&#110;&#046;&#107;&#110;&#105;&#103;&#104;&#116;&#064;&#109;&#104;&#114;&#097;&#046;&#103;&#115;&#105;&#046;&#103;&#111;&#118;&#046;&#117;&#107;\">&#115;&#104;&#097;&#114;&#111;&#110;&#046;&#107;&#110;&#105;&#103;&#104;&#116;&#064;&#109;&#104;&#114;&#097;&#046;&#103;&#115;&#105;&#046;&#103;&#111;&#118;&#046;&#117;&#107;</a> or <a href=\"&#109;&#097;&#105;&#108;&#116;&#111;:&#114;&#111;&#111;&#112;&#097;&#046;&#112;&#114;&#097;&#098;&#104;&#097;&#107;&#097;&#114;&#064;&#109;&#104;&#114;&#097;&#046;&#103;&#115;&#105;&#046;&#103;&#111;&#118;&#046;&#117;&#107;\">&#114;&#111;&#111;&#112;&#097;&#046;&#112;&#114;&#097;&#098;&#104;&#097;&#107;&#097;&#114;&#064;&#109;&#104;&#114;&#097;&#046;&#103;&#115;&#105;&#046;&#103;&#111;&#118;&#046;&#117;&#107;</a></p>\n\n<h4 id=\"clinical-aspects\">Clinical aspects</h4>\n\n<div class=\"address\"><div class=\"adr org fn\"><p>\n\nJonathan Plumb  \n<br />Medicines &amp; Healthcare products Regulatory Agency  \n<br />Floor 4  \n<br />151 Buckingham Palace Road  \n<br />London  \n<br />SW1W 9SZ\n<br />\n<br />Tel: 020 3080 7202 or 7293  \n<br />Fax: 020 8754 3965  \n<br />\n</p></div></div>\n\n<p>Email: <a href=\"&#109;&#097;&#105;&#108;&#116;&#111;:&#106;&#111;&#110;&#097;&#116;&#104;&#097;&#110;&#046;&#112;&#108;&#117;&#109;&#098;&#064;&#109;&#104;&#114;&#097;&#046;&#103;&#115;&#105;&#046;&#103;&#111;&#118;&#046;&#117;&#107;\">&#106;&#111;&#110;&#097;&#116;&#104;&#097;&#110;&#046;&#112;&#108;&#117;&#109;&#098;&#064;&#109;&#104;&#114;&#097;&#046;&#103;&#115;&#105;&#046;&#103;&#111;&#118;&#046;&#117;&#107;</a></p>\n\n<h4 id=\"how-to-report-adverse-incidents\">How to report adverse incidents</h4>\n\n<p>Please report via our website: <a rel=\"external\" href=\"http://www.mhra.gov.uk/Safetyinformation/Reportingsafetyproblems/Devices/index.htm\">Reporting adverse incidents involving medical devices</a>.  </p>\n\n<p>Further information about CAS can be found on the <a rel=\"external\" href=\"https://www.cas.dh.gov.uk/Home.aspx\">CAS website</a></p>\n\n<h2 id=\"northern-ireland\">Northern Ireland</h2>\n\n<p>Alerts in Northern Ireland will continue to be distributed via the NI SABS system.</p>\n\n<p>Enquiries and adverse incident reports in Northern Ireland should be addressed to:  </p>\n\n<div class=\"address\"><div class=\"adr org fn\"><p>\n\nNorthern Ireland Adverse Incident Centre  \n<br />Health Estates Investment Group  \n<br />Room 17  \n<br />Annex 6  \n<br />Castle Buildings  \n<br />Stormont Estate  \n<br />Dundonald  \n<br />BT4 3SQ\n<br />\n<br />Tel: 02890 523 704  \n<br />Fax: 02890 523 900\n<br />\n</p></div></div>\n\n<p>Email: <a href=\"&#109;&#097;&#105;&#108;&#116;&#111;:&#078;&#073;&#065;&#073;&#067;&#064;&#100;&#104;&#115;&#115;&#112;&#115;&#110;&#105;&#046;&#103;&#111;&#118;&#046;&#117;&#107;\">&#078;&#073;&#065;&#073;&#067;&#064;&#100;&#104;&#115;&#115;&#112;&#115;&#110;&#105;&#046;&#103;&#111;&#118;&#046;&#117;&#107;</a></p>\n\n<h4 id=\"how-to-report-adverse-incidents-in-northern-ireland\">How to report adverse incidents in Northern Ireland</h4>\n\n<p>Please report directly to NIAIC, further information can be found on the <a rel=\"external\" href=\"http://www.dhsspsni.gov.uk/niaic\">NIAIC website</a> .  </p>\n\n<p>Further information about SABS can be found on the <a rel=\"external\" href=\"http://sabs.dhsspsni.gov.uk/NISABS/default.aspx?CATID=3\">SABS website</a> .</p>\n\n<h2 id=\"scotland\">Scotland</h2>\n\n<p>Enquiries and adverse incident reports in Scotland should be addressed to:</p>\n\n<div class=\"address\"><div class=\"adr org fn\"><p>\n\nIncident Reporting and Investigation Centre  \n<br />Health Facilities Scotland  \n<br />NHS National Services Scotland  \n<br />Gyle Square  \n<br />1 South Gyle Crescent  \n<br />Edinburgh  \n<br />EH12 9EB\n<br />\n<br />Tel: 0131 275 7575  \n<br />Fax: 0131 314 0722\n<br />\n</p></div></div>\n\n<p>Email: <a href=\"&#109;&#097;&#105;&#108;&#116;&#111;:&#110;&#115;&#115;&#046;&#105;&#114;&#105;&#099;&#064;&#110;&#104;&#115;&#046;&#110;&#101;&#116;\">&#110;&#115;&#115;&#046;&#105;&#114;&#105;&#099;&#064;&#110;&#104;&#115;&#046;&#110;&#101;&#116;</a></p>\n\n<p><a rel=\"external\" href=\"http://www.hfs.scot.nhs.uk/online-services/incident-reporting-and-investigation-centre-iric/\">Health Facilities Scotland Incident Reporting and Investigation Centre (IRIC)</a> </p>\n\n<h2 id=\"wales\">Wales</h2>\n\n<p>Enquiries in Wales should be addressed to:</p>\n\n<div class=\"address\"><div class=\"adr org fn\"><p>\n\nDr Sara Hayes  \n<br />Senior Medical Officer  \n<br />Medical Device Alerts  \n<br />Welsh Assembly Government  \n<br />Cathays Park  \n<br />Cardiff  \n<br />CF10 3NQ\n<br />\n<br />Tel: 029 2082 3922  \n<br />\n</p></div></div>\n\n<p>Email: <a href=\"&#109;&#097;&#105;&#108;&#116;&#111;:&#072;&#097;&#122;&#045;&#065;&#105;&#099;&#064;&#119;&#097;&#108;&#101;&#115;&#046;&#103;&#115;&#105;&#046;&#103;&#111;&#118;&#046;&#117;&#107;\">&#072;&#097;&#122;&#045;&#065;&#105;&#099;&#064;&#119;&#097;&#108;&#101;&#115;&#046;&#103;&#115;&#105;&#046;&#103;&#111;&#118;&#046;&#117;&#107;</a></p>\n\n<h2 id=\"download-documents\">Download documents</h2>\n\n<p><a rel=\"external\" href=\"https://assets.digital.cabinet-office.gov.uk/media/5485ac1de5274a428d000281/con120287.pdf\"> Medical Device Alert: All Plum A+ infusion pumps manufactured by Hospira Inc (MDA/2011/066) (204Kb)</a></p>\n"},{"content_type":"text/govspeak","content":"## Device\r\n\r\n![InlineAttachment:con120288.jpg]\r\n\r\nAll Plum A+ infusion pumps:  \r\n  \r\n Pump |   |  List number |   \r\n Plum A+ Infusion Pump |   |  11971 |   \r\n Plum A+ 3 Infusion Pump System v 10.3 |   |  12348 |   \r\n Plum A+ Infusion Pump v 11.3 |   |  12391 |   \r\n Plum A+ 3 Infusion Pump v 11.3 |   |  12618 |   \r\n Plum A+ 3 with Hospira MedNet Software |   |  20678 |   \r\n Plum A+ Driver |   |  20792 | \r\n\r\nManufactured by Hospira Inc.\r\n\r\n## Problem\r\n\r\nRisk of delay or interruption to treatment.\r\n\r\nThe audible alarm on all listed Plum A+ infusion pumps may fail.\r\n\r\nThe visual alarm is not affected. However, if the user does not notice the visual alarm they may be unaware of an interruption to the infusion eg air-in-line or occlusion.\r\n\r\nImproper mounting of components, poor soldering, and breakage of internal wiring connections may lead to failure of the audible alarm.\r\n\r\nThe [InlineAttachment:con111685.pdf] (905Kb) advises users to test the audible alarm before each use of the pump as an interim measure. However, these tests will not predict if the audible alarm will fail and will only indicate if it has already failed. It is possible for the audible alarm to fail in use, even after the test has been performed.\r\n\r\nHospira is modifying the design of the audible alarm to resolve this problem. Once this has been completed, Hospira will contact users to arrange for replacement.\r\n\r\n## Action  \r\n  \r\n  * Identify affected pumps.  \r\n  * Consider using an alternative device if an undetected interruption to an infusion could compromise patient safety.  \r\n  * If an alternative is not available, perform the pre-use checks detailed in the manufacturer’s [InlineAttachment:con111685.pdf] (905Kb) (dated 2 March 2011). Be aware that the audible alarm may still fail in some pumps even after the checks have been completed.  \r\n  \r\n## Distribution\r\n\r\nThis MDA has been sent to:  \r\n  \r\n  * NHS trusts in England (Chief Executives)  \r\n  * Care Quality Commission (CQC) (Headquarters) for information  \r\n  * HSC trusts in Northern Ireland (Chief Executives)  \r\n  * NHS boards in Scotland (Equipment Co-ordinators)  \r\n  * Local authorities in Scotland (Equipment Co-ordinators)  \r\n  * NHS boards and trusts in Wales (Chief Executives)  \r\n  * Primary care trusts in England (Chief Executives)  \r\n  * Social services in England (Directors)  \r\n  \r\n#### Onward distribution  \r\n\r\nPlease bring this notice to the attention of relevant employees in your establishment. Below is a suggested list of recipients.\r\n\r\nTrusts  \r\nCAS and SABS (NI) liaison officers for onward distribution to all relevant staff including:  \r\n  \r\n  * A&E departments  \r\n  * Adult intensive care units  \r\n  * All wards  \r\n  * Biomedical engineering staff  \r\n  * Clinical governance leads  \r\n  * EBME departments  \r\n  * Equipment stores  \r\n  * Health and safety managers  \r\n  * In-house maintenance staff  \r\n  * IV nurse specialists  \r\n  * Medical directors  \r\n  * Nursing executive directors  \r\n  * Operating departments  \r\n  * Paediatric intensive care units  \r\n  * Pain control teams  \r\n  * Risk managers  \r\n  * Supplies managers  \r\n  * Theatres  \r\n  \r\nPrimary care trusts  \r\nCAS liaison officers for onward distribution to all relevant staff including:  \r\n  \r\n  * Community hospitals  \r\n  * Hospital at home  \r\n  * Equipment libraries and stores  \r\n  * Palliative care teams  \r\n  \r\nSocial services  \r\nLiaison officers for onward distribution to all relevant staff including:  \r\n  \r\n  * Care management team managers  \r\n  * Equipment supplies managers  \r\n  * In-house residential care homes  \r\n  * Loan store managers  \r\n  \r\n#### Independent distribution  \r\n  \r\nEstablishments registered with the Care Quality Commission (CQC) (England only)  \r\nThis alert should be read by:  \r\n  \r\n  * Care homes providing nursing care (adults)  \r\n  * Clinics  \r\n  * Hospices  \r\n  * Hospitals in the independent sector  \r\n  \r\nPlease note: CQC and OFSTED do not distribute these alerts. Independent healthcare providers and social care providers can sign up to receive MDAs directly from the Department of Health’s Central Alerting System (CAS) by sending an email to: [safetyalerts@dh.gsi.gov.uk](mailto:safetyalerts@dh.gsi.gov.uk) and requesting this facility.  \r\n\r\n## Manufacturer contact\r\n\r\n$A\r\nRobert Cookes  \r\nCustomer Services Manager  \r\nHospira UK  \r\nQueensway  \r\nRoyal Leamington Spa  \r\nCV31 3RW\r\n\r\nTel: 0800 028 7304  \r\nFax: 0800 028 7305  \r\n$A\r\n\r\nEmail: [custserv@hospira.com](mailto:custserv@hospira.com)\r\n\r\n## Feedback\r\n\r\nIf you have any comments or feedback on this Medical Device Alert, please email us at: [dts@mhra.gsi.gov.uk](mailto:dts@mhra.gsi.gov.uk) \r\n\r\n## England\r\n\r\nIf you are in England, please send enquiries about this notice to the MHRA, quoting reference number MDA/2011/066 or 2011/003/014/291/003.\r\n\r\n#### Technical aspects  \r\n\r\n$A\r\nSharon Knight or Roopa Prabhakar  \r\nMedicines & Healthcare products Regulatory Agency  \r\nFloor 4  \r\n151 Buckingham Palace Road  \r\nLondon  \r\nSW1W 9SZ\r\n\r\nTel: 020 3080 7202 or 7293  \r\nFax: 020 8754 3965  \r\n$A\r\n\r\nEmail: [sharon.knight@mhra.gsi.gov.uk](mailto:sharon.knight@mhra.gsi.gov.uk) or [roopa.prabhakar@mhra.gsi.gov.uk](mailto:roopa.prabhakar@mhra.gsi.gov.uk)\r\n\r\n#### Clinical aspects  \r\n\r\n$A\r\nJonathan Plumb  \r\nMedicines & Healthcare products Regulatory Agency  \r\nFloor 4  \r\n151 Buckingham Palace Road  \r\nLondon  \r\nSW1W 9SZ\r\n\r\nTel: 020 3080 7202 or 7293  \r\nFax: 020 8754 3965  \r\n$A\r\n\r\nEmail: [jonathan.plumb@mhra.gsi.gov.uk](mailto:jonathan.plumb@mhra.gsi.gov.uk)\r\n\r\n#### How to report adverse incidents  \r\n\r\nPlease report via our website: [Reporting adverse incidents involving medical devices](http://www.mhra.gov.uk/Safetyinformation/Reportingsafetyproblems/Devices/index.htm).  \r\n\r\nFurther information about CAS can be found on the [CAS website](https://www.cas.dh.gov.uk/Home.aspx)\r\n\r\n## Northern Ireland\r\n\r\nAlerts in Northern Ireland will continue to be distributed via the NI SABS system.\r\n\r\nEnquiries and adverse incident reports in Northern Ireland should be addressed to:  \r\n  \r\n\r\n$A\r\nNorthern Ireland Adverse Incident Centre  \r\nHealth Estates Investment Group  \r\nRoom 17  \r\nAnnex 6  \r\nCastle Buildings  \r\nStormont Estate  \r\nDundonald  \r\nBT4 3SQ\r\n\r\nTel: 02890 523 704  \r\nFax: 02890 523 900\r\n$A\r\n\r\nEmail: [NIAIC@dhsspsni.gov.uk](mailto:NIAIC@dhsspsni.gov.uk)\r\n\r\n#### How to report adverse incidents in Northern Ireland  \r\n\r\nPlease report directly to NIAIC, further information can be found on the [NIAIC website](http://www.dhsspsni.gov.uk/niaic) .  \r\n\r\nFurther information about SABS can be found on the [SABS website](http://sabs.dhsspsni.gov.uk/NISABS/default.aspx?CATID=3) .\r\n\r\n## Scotland\r\n\r\nEnquiries and adverse incident reports in Scotland should be addressed to:\r\n\r\n\r\n$A\r\nIncident Reporting and Investigation Centre  \r\nHealth Facilities Scotland  \r\nNHS National Services Scotland  \r\nGyle Square  \r\n1 South Gyle Crescent  \r\nEdinburgh  \r\nEH12 9EB\r\n\r\nTel: 0131 275 7575  \r\nFax: 0131 314 0722\r\n$A\r\n\r\nEmail: [nss.iric@nhs.net](mailto:nss.iric@nhs.net)\r\n\r\n[Health Facilities Scotland Incident Reporting and Investigation Centre (IRIC)](http://www.hfs.scot.nhs.uk/online-services/incident-reporting-and-investigation-centre-iric/) \r\n\r\n## Wales\r\n\r\nEnquiries in Wales should be addressed to:\r\n\r\n\r\n$A\r\nDr Sara Hayes  \r\nSenior Medical Officer  \r\nMedical Device Alerts  \r\nWelsh Assembly Government  \r\nCathays Park  \r\nCardiff  \r\nCF10 3NQ\r\n\r\nTel: 029 2082 3922  \r\n$A\r\n\r\nEmail: [Haz-Aic@wales.gsi.gov.uk](mailto:Haz-Aic@wales.gsi.gov.uk)\r\n\r\n## Download documents\r\n\r\n[InlineAttachment:con120287.pdf]\r\n"}],"max_cache_time":10,"temporary_update_type":false,"attachments":[{"content_id":"9651d301-8a5e-47c1-a43d-56ede895124c","title":"manufacturer’s FSN","url":"https://assets.digital.cabinet-office.gov.uk/media/5485ac1c40f0b6024100027b/con111685.pdf","updated_at":"2014-12-08T13:48:12Z","created_at":"2014-12-08T13:48:14Z","content_type":"application/pdf"},{"content_id":"ebd5d274-79ea-4895-a85e-627d4e950957","title":"Field Safety Notice","url":"https://assets.digital.cabinet-office.gov.uk/media/5485ac1ded915d4c1000028d/con111685.pdf","updated_at":"2014-12-08T13:48:12Z","created_at":"2014-12-08T13:48:14Z","content_type":"application/pdf"},{"content_id":"1ea6e414-fb24-434a-9f91-259b49ddb3db","title":" Medical Device Alert: All Plum A+ infusion pumps manufactured by Hospira Inc (MDA/2011/066) (204Kb)","url":"https://assets.digital.cabinet-office.gov.uk/media/5485ac1de5274a428d000281/con120287.pdf","updated_at":"2014-12-08T13:48:13Z","created_at":"2014-12-08T13:48:14Z","content_type":"application/pdf"},{"content_id":"6c276fec-f4f3-42ed-ae89-144d70e3aef3","title":"Plum A+ infusion pump","url":"https://assets.digital.cabinet-office.gov.uk/media/5485ac1e40f0b60244000295/con120288.jpg","updated_at":"2014-12-08T13:48:13Z","created_at":"2014-12-08T13:48:14Z","content_type":"application/jpg"}],"headers":[{"text":"Device","level":2,"id":"device"},{"text":"Problem","level":2,"id":"problem"},{"text":"Action","level":2,"id":"action"},{"text":"Distribution","level":2,"id":"distribution"},{"text":"Manufacturer contact","level":2,"id":"manufacturer-contact"},{"text":"Feedback","level":2,"id":"feedback"},{"text":"England","level":2,"id":"england"},{"text":"Northern Ireland","level":2,"id":"northern-ireland"},{"text":"Scotland","level":2,"id":"scotland"},{"text":"Wales","level":2,"id":"wales"},{"text":"Download documents","level":2,"id":"download-documents"}]},"routes":[{"path":"/drug-device-alerts/medical-device-alert-plum-a-infusion-pumps-potential-failure","type":"exact"}],"redirects":[],"publishing_app":"specialist-publisher","rendering_app":"government-frontend","need_ids":[],"phase":"live","analytics_identifier":null,"document_type":"medical_safety_alert","schema_name":"specialist_document","first_published_at":"2016-02-29T09:24:10Z","base_path":"/drug-device-alerts/medical-device-alert-plum-a-infusion-pumps-potential-failure","description":"(Hospira Inc) audible alarm on listed Plum A+ infusion pumps may fail, which could cause a delay or interruption to treatment. (MDA/2011/066)","content_id":"177238b4-a839-4059-81fe-98191ac3526b","locale":"en","expanded_links":{"organisations":[{"analytics_identifier":"EA63","api_path":"/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency","base_path":"/government/organisations/medicines-and-healthcare-products-regulatory-agency","content_id":"240f72bd-9a4d-4f39-94d9-77235cadde8e","description":null,"document_type":"organisation","locale":"en","public_updated_at":"2015-06-29T14:33:29Z","schema_name":"placeholder","title":"Medicines and Healthcare products Regulatory Agency","withdrawn":false,"details":{"brand":"department-of-health","logo":{"formatted_title":"Medicines &amp; Healthcare products<br/>Regulatory Agency","crest":"single-identity"}},"links":{}}],"finder":[{"analytics_identifier":null,"api_path":"/api/content/drug-device-alerts","base_path":"/drug-device-alerts","content_id":"1e9c0ada-5f7e-43cc-a55f-cc32757edaa3","description":"Find alerts and recalls issued by MHRA","document_type":"finder","locale":"en","public_updated_at":"2017-03-30T10:34:00Z","schema_name":"finder","title":"Alerts and recalls for drugs and medical devices","withdrawn":false,"details":{"document_noun":"alert","filter":{"document_type":"medical_safety_alert"},"format_name":"Medical safety alert","show_summaries":true,"facets":[{"key":"alert_type","name":"Alert type","type":"text","preposition":"for","display_as_result_metadata":true,"filterable":true,"allowed_values":[{"label":"Drug alert","value":"drugs"},{"label":"Medical device alert","value":"devices"},{"label":"Field safety notice","value":"field-safety-notices"},{"label":"Drug alert: company-led","value":"company-led-drugs"}]},{"key":"medical_specialism","name":"Medical specialism","type":"text","preposition":"about","display_as_result_metadata":true,"filterable":true,"allowed_values":[{"label":"Anaesthetics","value":"anaesthetics"},{"label":"Cardiology","value":"cardiology"},{"label":"Care home staff","value":"care-home-staff"},{"label":"Cosmetic surgery","value":"cosmetic-surgery"},{"label":"Critical care","value":"critical-care"},{"label":"Dentistry","value":"dentistry"},{"label":"General practice","value":"general-practice"},{"label":"General surgery","value":"general-surgery"},{"label":"Haematology and oncology","value":"haematology-oncology"},{"label":"Infection prevention","value":"infection-prevention"},{"label":"Obstetrics and gynaecology","value":"obstetrics-gynaecology"},{"label":"Ophthalmology","value":"ophthalmology"},{"label":"Orthopaedics","value":"orthopaedics"},{"label":"Paediatrics","value":"paediatrics"},{"label":"Pathology","value":"pathology"},{"label":"Pharmacy","value":"pharmacy"},{"label":"Physiotherapy and occupational therapy","value":"physiotherapy-occupational-therapy"},{"label":"Radiology","value":"radiology"},{"label":"Renal medicine","value":"renal-medicine"},{"label":"Theatre practitioners","value":"theatre-practitioners"},{"label":"Urology","value":"urology"},{"label":"Vascular and cardiac surgery","value":"vascular-cardiac-surgery"}]},{"key":"issued_date","name":"Issued","short_name":"Issued","type":"date","preposition":"issued","display_as_result_metadata":true,"filterable":true}],"default_documents_per_page":50},"links":{}}],"available_translations":[{"title":"Plum A+ infusion pumps - potential failure","public_updated_at":"2014-12-17T14:56:15Z","analytics_identifier":null,"document_type":"medical_safety_alert","schema_name":"specialist_document","base_path":"/drug-device-alerts/medical-device-alert-plum-a-infusion-pumps-potential-failure","description":"(Hospira Inc) audible alarm on listed Plum A+ infusion pumps may fail, which could cause a delay or interruption to treatment. (MDA/2011/066)","api_path":"/api/content/drug-device-alerts/medical-device-alert-plum-a-infusion-pumps-potential-failure","withdrawn":false,"content_id":"177238b4-a839-4059-81fe-98191ac3526b","locale":"en"}]},"format":"specialist_document","navigation_document_supertype":"other","user_journey_document_supertype":"thing","email_document_supertype":"other","government_document_supertype":"other","payload_version":0}